urticaria

Reading File
Finding Sources
Searching Images

urticaria hives wheals skin

A series of three clinical photographs demonstrating the dermatological resolution of urticaria (hives) across three anatomical regions: the knee joint (A), the lateral waist (B), and the elbow (C). The images show characteristic wheals—edematous, circumscribed, and slightly elevated skin lesions. Panel A displays the knee area with subtle, flesh-colored to slightly erythematous elevations and an uneven skin texture consistent with resolving wheals. Panel B shows the lateral waist with faint, linear, and confluent dermal edema. Panel C depicts the elbow where the lesions have largely flattened, leaving only minimal, faint markings on the skin surface. The progression illustrates the transient nature of urticarial lesions as they gradually diminish in size and elevation. This visual serves as an educational reference for identifying skin morphology in the recovery phase of an acute urticarial reaction, emphasizing the characteristic lack of secondary skin changes (such as scaling or scarring) during the resolution of wheals.

A series of three clinical photographs demonstrating the dermatological resolution of urticaria (hives) across three anatomical regions: the knee joint (A), the lateral waist (B), and the elbow (C). The images show characteristic wheals—edematous, circumscribed, and slightly elevated skin lesions. Panel A displays the knee area with subtle, flesh-colored to slightly erythematous elevations and an uneven skin texture consistent with resolving wheals. Panel B shows the lateral waist with faint, linear, and confluent dermal edema. Panel C depicts the elbow where the lesions have largely flattened, leaving only minimal, faint markings on the skin surface. The progression illustrates the transient nature of urticarial lesions as they gradually diminish in size and elevation. This visual serves as an educational reference for identifying skin morphology in the recovery phase of an acute urticarial reaction, emphasizing the characteristic lack of secondary skin changes (such as scaling or scarring) during the resolution of wheals.

A clinical photograph showing a close-up of a child's lower extremity demonstrating urticaria. The image displays multiple raised, edematous skin lesions known as wheals or hives. These lesions are characterized by pale-to-skin-colored central swellings of varying sizes and irregular shapes, surrounded by a distinct zone of erythema (redness). The distribution is scattered across the leg, illustrating the typical appearance of a hypersensitivity reaction or allergic response. This image serves as an educational reference for identifying cutaneous manifestations of urticaria, focusing on the morphology of superficial dermal edema and associated inflammatory flare.

A clinical photograph showing a close-up of a child's lower extremity demonstrating urticaria. The image displays multiple raised, edematous skin lesions known as wheals or hives. These lesions are characterized by pale-to-skin-colored central swellings of varying sizes and irregular shapes, surrounded by a distinct zone of erythema (redness). The distribution is scattered across the leg, illustrating the typical appearance of a hypersensitivity reaction or allergic response. This image serves as an educational reference for identifying cutaneous manifestations of urticaria, focusing on the morphology of superficial dermal edema and associated inflammatory flare.

Clinical photograph of a pediatric patient's bilateral lower limbs demonstrating classic urticaria (hives). The image shows multiple discrete and confluent wheals distributed across the thighs. Morphologically, the lesions are characterized by raised, edematous, superficial swellings of varying sizes. The central portions of the wheals appear pale or skin-colored, while the peripheries exhibit varying degrees of erythema. These findings represent a type I hypersensitivity reaction or mast cell degranulation, leading to dermal edema. This visual evidence is a key diagnostic clinical sign for acute urticaria, commonly used in dermatology and pediatric curricula to differentiate transient wheals from other types of papular eruptions or inflammatory skin conditions.

Clinical photograph of a pediatric patient's bilateral lower limbs demonstrating classic urticaria (hives). The image shows multiple discrete and confluent wheals distributed across the thighs. Morphologically, the lesions are characterized by raised, edematous, superficial swellings of varying sizes. The central portions of the wheals appear pale or skin-colored, while the peripheries exhibit varying degrees of erythema. These findings represent a type I hypersensitivity reaction or mast cell degranulation, leading to dermal edema. This visual evidence is a key diagnostic clinical sign for acute urticaria, commonly used in dermatology and pediatric curricula to differentiate transient wheals from other types of papular eruptions or inflammatory skin conditions.

Searching PubMed

urticaria management guidelines

Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Loading Image
Reading File
Reading File
I now have excellent content from multiple authoritative textbooks. Let me compile the comprehensive answer.

Urticaria (Hives)

Urticaria - edematous wheals with erythema on the arm
Fig. Urticaria: edematous plaques with pale centers and red borders (Rosen's Emergency Medicine)

Definition

Urticaria (hives) is one of the most common cutaneous reaction patterns, characterized by circumscribed, raised, pruritic, evanescent areas of edema involving the superficial dermis - known as wheals. A wheal can appear reddish or whitish depending on the degree of edema. The spectrum ranges from simple wheals to angioedema (deep dermis/subcutaneous involvement). About 15-20% of the population experiences urticaria at some point in their lifetime.
  • Goldman-Cecil Medicine, p. 4300
  • Rosen's Emergency Medicine, p. 2413

Classification

By Duration

AcuteChronic
Duration< 6 weeks≥ 6 weeks
Common causesDrugs, foods, infections, vaccinesSpontaneous/idiopathic, autoimmune, physical
More common inChildren (atopic dermatitis)Women 20-40 years old
Chronic urticaria is further divided into:
  • Chronic Spontaneous Urticaria (CSU): no identifiable trigger (66-93% of chronic cases)
  • Inducible/Physical Urticaria: provoked by specific physical stimuli

Chronic Urticaria Types (Harrison's Table 363-1)

Acute triggers: drugs (NSAIDs, antimicrobials, ACE inhibitors, opioids, radiocontrast), foods, infections (viral, bacterial, parasitic), vaccine reactions, insect stings, transfusions
Chronic forms:
  • Spontaneous/idiopathic
  • Autoimmune (functional IgE autoantibodies)
  • Dermatographism (linear wheal from skin stroking; 2-5% of population)
  • Cholinergic urticaria (small 1-2 mm wheals + large erythema; triggered by heat, exercise, fever)
  • Pressure urticaria (sustained pressure - belt, shoulder strap)
  • Cold, solar, vibratory, aquagenic urticaria
  • Mastocytosis, urticarial vasculitis, hereditary angioedema (HAE)
  • Harrison's Principles of Internal Medicine 22E, p. 363
  • Fitzpatrick's Dermatology, Vol. 1-2

Pathophysiology

The core event is local mast cell degranulation with release of:
  • Histamine (primary mediator)
  • Slow-reacting substance of anaphylaxis (leukotrienes)
  • Bradykinin, kallikrein, acetylcholine
This leads to transvascular fluid extravasation and localized dermal edema.

Mechanisms

  1. Immunologic:
    • IgE-mediated (Type I hypersensitivity)
    • Autoimmune (functional IgG autoantibodies against IgE or FcεRI)
    • Immune complex-mediated
    • Complement-kinin dependent
  2. Non-immunologic:
    • Direct mast cell degranulation (drugs like opioids, aspirin, foods like strawberries/lobster)
    • Vasoactive stimuli
  • Goldman-Cecil Medicine, p. 4302
  • Rosen's Emergency Medicine, p. 2413

Common Causes

CategoryExamples
DrugsPenicillin, aspirin/NSAIDs (most common); also opioids, ACE inhibitors, radiocontrast
FoodsSeafood, tree nuts, eggs, peanuts (IgE-mediated); strawberries, lobster (direct histamine release)
InfectionsRhinovirus, rotavirus, hepatitis, EBV (mono), Coxsackievirus; Candida, dermatophytes, parasites
PhysicalCold, heat, pressure, sun, vibration, water, exercise
ContactFoods, animal dander/saliva, plants, topical medications, cosmetics, chemicals
Note: Penicillin traces may persist in dairy products and other medications. Aspirin's mechanism is likely non-immunologic and effects can persist for weeks.

Clinical Features

  • Wheals: Edematous plaques, pale center + red border ("wheal and flare"), blanching on pressure
  • Pruritus: Hallmark symptom
  • Evanescent: Individual lesions typically last < 24 hours (this is a key diagnostic feature)
  • New lesions continuously develop while old ones resolve
  • May coexist with angioedema (deeper swelling - face, lips, tongue, throat)
  • Angioedema without wheals occurs in 1-13% of CSU patients

Differential Diagnosis

  • Drug eruption / viral exanthem
  • Erythema multiforme
  • Erythema marginatum
  • Urticarial vasculitis (lesions persist > 24h, may bruise)
  • Juvenile rheumatoid arthritis
  • Bullous pemphigoid (urticarial stage)
  • Neutrophilic urticaria
  • Mastocytosis
Key differentiating feature: True urticaria resolves within 24 hours without residual skin changes (no bruising, scaling, or scarring).
  • Fitzpatrick's Dermatology, p. 46
  • Rosen's Emergency Medicine, p. 2413

Management

Step 1: Remove the trigger

Identify and eliminate the causative agent when possible.

Step 2: Antihistamines (First-line)

  • H1 antihistamines (preferred non-sedating): Cetirizine, fexofenadine, loratadine
  • Sedating H1: Hydroxyzine (useful for pruritus relief)
  • H2 blocker addition: Can be added in chronic or refractory cases (e.g., ranitidine, famotidine)
  • For chronic urticaria: long-term combination H1+H2 antihistamines

Step 3: Corticosteroids (Adjunctive)

  • Moderate/severe urticaria: prednisone or dexamethasone
  • Recurrent urticaria: 14-21 day course with taper
  • Chronic steroid use is not recommended

Step 4: Advanced/Refractory Therapy

  • Omalizumab (anti-IgE monoclonal antibody): highly effective for chronic spontaneous urticaria - a 2025 meta-analysis confirms its efficacy and safety in pediatric CSU as well
  • Cyclosporine: second-line immunosuppressant for CSU
  • A 2024 systematic review on acute urticaria treatment found that antihistamines remain the cornerstone, with corticosteroids as adjuncts
  • Rosen's Emergency Medicine, p. 2414
  • Goldman-Cecil Medicine, p. 4302

Special Considerations

SituationNotes
Angioedema with airway compromiseTreat as anaphylaxis: epinephrine IM, airway management
Chronic spontaneous urticariaHalf of patients have disease for 5+ years; investigate for autoimmune cause
DermatographismUsually resolves within 5 years; reassurance + antihistamines
Cholinergic urticariaAvoid triggers (heat, exercise); H1 antihistamines ± beta-blockers
Cold urticariaRisk of anaphylaxis with cold water immersion; carry epinephrine
Pressure urticariaOften accompanies CSU; responds poorly to antihistamines

Key Points for Boards/Exams

  1. Urticaria lasting < 6 weeks = acute; ≥ 6 weeks = chronic
  2. Individual wheals resolve in < 24 hours - if they persist longer, consider urticarial vasculitis
  3. Most common drugs: penicillin and aspirin
  4. Most chronic urticaria is idiopathic/spontaneous
  5. First-line: non-sedating H1 antihistamines
  6. Refractory CSU: omalizumab (anti-IgE)
  7. Angioedema of the larynx/tongue = emergency - epinephrine

Types of Give me detailed notes about urticaria

Finding Sources
Finding Sources
Searching Images

urticaria types wheals angioedema dermatographism cholinergic

Clinical photography of a patient with cholinergic urticaria showing multiple small, erythematous, blanching wheals on the forearm. Imaging modality is clinical photography; technique involves a high-resolution, color-balanced image capturing superficial skin lesions in a macro-clinical view. The wheals are transient, pruritic, and vary in size from a few millimeters to up to several millimeters, with well-demarcated borders and pale centers. Triggered by heat, exercise, and emotional stress, the lesions can appear soon after sweating and typically resolve within minutes to hours. This presentation correlates with cholinergic urticaria, a physical urticaria subtype linked to cholinergic stimuli, requiring history of triggers and symptom timing. Differential diagnoses include other urticarias and heat-induced dermatoses; diagnostic significance lies in distinguishing exercise/sweat-induced wheals from dermatographism or drug reactions to guide management. Clinical utility includes educating patients on trigger mitigation, optimizing antihistamine therapy, and evaluating for underlying mast cell disorders if atypical features arise. Chronic management includes non-sedating H1 antihistamines at standard or increased dosing, with occasional H2 blockade. Patients are advised to avoid overheating, wear breathable clothing, and perform graded exercise; epinephrine is reserved for rare anaphylaxis. In ambiguous cases, exercise-provoked challenges or sweat tests may help; history differentiates from other physical urticarias.

Clinical photography of a patient with cholinergic urticaria showing multiple small, erythematous, blanching wheals on the forearm. Imaging modality is clinical photography; technique involves a high-resolution, color-balanced image capturing superficial skin lesions in a macro-clinical view. The wheals are transient, pruritic, and vary in size from a few millimeters to up to several millimeters, with well-demarcated borders and pale centers. Triggered by heat, exercise, and emotional stress, the lesions can appear soon after sweating and typically resolve within minutes to hours. This presentation correlates with cholinergic urticaria, a physical urticaria subtype linked to cholinergic stimuli, requiring history of triggers and symptom timing. Differential diagnoses include other urticarias and heat-induced dermatoses; diagnostic significance lies in distinguishing exercise/sweat-induced wheals from dermatographism or drug reactions to guide management. Clinical utility includes educating patients on trigger mitigation, optimizing antihistamine therapy, and evaluating for underlying mast cell disorders if atypical features arise. Chronic management includes non-sedating H1 antihistamines at standard or increased dosing, with occasional H2 blockade. Patients are advised to avoid overheating, wear breathable clothing, and perform graded exercise; epinephrine is reserved for rare anaphylaxis. In ambiguous cases, exercise-provoked challenges or sweat tests may help; history differentiates from other physical urticarias.

This is a dermatology clinical photograph of the skin surface demonstrating the typical small, transient wheals seen in cholinergic urticaria. The image shows numerous pinpoint to 3–4 mm erythematous, raised plaques scattered across the forearm in a crops-like distribution. Each wheal shows central blanching with a slightly edematous, ring-like border and a blanching halo consistent with superficial dermal edema. The lesions are pruritic and short-lived, usually resolving within 1–2 hours, often appearing after heat exposure, exercise, or emotional stress. In cholinergic urticaria, symptoms may be accompanied by warmth, sweating, or mild warmth-induced flushing. The focal photodermatographic appearance is not necessarily specific but the small size, rapid onset following provocative stimuli, and distribution pattern strongly support a physical urticaria rather than mast cell neoplasia or dermatitis. Clinically relevant features include the ability to trigger crops, readiness to respond to oral antihistamines, and potential improvement with pre-exercise cooling or preventive antihistamine therapy. The differential diagnosis includes other physical urticarias (dermographism, heat urticaria), ordinary urticaria, papular urticaria, and less commonly urticarial vasculitis. This image is most useful for educational illustration of cholinergic urticaria triggers: exercise, heat, stress; and for training in clinical recognition and patient counseling.

This is a dermatology clinical photograph of the skin surface demonstrating the typical small, transient wheals seen in cholinergic urticaria. The image shows numerous pinpoint to 3–4 mm erythematous, raised plaques scattered across the forearm in a crops-like distribution. Each wheal shows central blanching with a slightly edematous, ring-like border and a blanching halo consistent with superficial dermal edema. The lesions are pruritic and short-lived, usually resolving within 1–2 hours, often appearing after heat exposure, exercise, or emotional stress. In cholinergic urticaria, symptoms may be accompanied by warmth, sweating, or mild warmth-induced flushing. The focal photodermatographic appearance is not necessarily specific but the small size, rapid onset following provocative stimuli, and distribution pattern strongly support a physical urticaria rather than mast cell neoplasia or dermatitis. Clinically relevant features include the ability to trigger crops, readiness to respond to oral antihistamines, and potential improvement with pre-exercise cooling or preventive antihistamine therapy. The differential diagnosis includes other physical urticarias (dermographism, heat urticaria), ordinary urticaria, papular urticaria, and less commonly urticarial vasculitis. This image is most useful for educational illustration of cholinergic urticaria triggers: exercise, heat, stress; and for training in clinical recognition and patient counseling.

Clinical photograph of bilateral forearms showing multiple discrete 5 mm erythematous, blanchable wheals consistent with cholinergic urticaria precipitated by exercise. Lesions are superficial, well defined, round-to-oval, slightly raised, and distributed patchily across extensor surfaces of the forearms. The wheals appear shortly after exertion or warm ambient conditions and resolve within minutes to an hour, often preceding or accompanying mild pruritus. The image demonstrates a transient urticarial eruption without mucosal involvement or vesiculation. From a pathophysiologic perspective, cholinergic urticaria results from mast cell degranulation and histamine release triggered by increased core temperature and sweating; histologic findings (if biopsy were available) would show dermal edema with perivascular inflammatory infiltrate rich in eosinophils. Clinically, these findings aid differentiation from other physical urticarias such as heat urticaria, solar urticaria, or pressure urticaria, and from non-urticarial pruritic eruptions. This photograph supports diagnostic consideration in patients with exercise-induced pruritic wheals and provides material for education on recognition, documentation, and management planning. Relevance spans dermatology, allergology, pediatrics, and sports medicine; can guide antihistamine therapy, pre-exercise prophylaxis, and patient counseling on trigger avoidance and skin care during heat stress. Documentation of such patterns supports longitudinal monitoring and therapeutic response assessment.

Clinical photograph of bilateral forearms showing multiple discrete 5 mm erythematous, blanchable wheals consistent with cholinergic urticaria precipitated by exercise. Lesions are superficial, well defined, round-to-oval, slightly raised, and distributed patchily across extensor surfaces of the forearms. The wheals appear shortly after exertion or warm ambient conditions and resolve within minutes to an hour, often preceding or accompanying mild pruritus. The image demonstrates a transient urticarial eruption without mucosal involvement or vesiculation. From a pathophysiologic perspective, cholinergic urticaria results from mast cell degranulation and histamine release triggered by increased core temperature and sweating; histologic findings (if biopsy were available) would show dermal edema with perivascular inflammatory infiltrate rich in eosinophils. Clinically, these findings aid differentiation from other physical urticarias such as heat urticaria, solar urticaria, or pressure urticaria, and from non-urticarial pruritic eruptions. This photograph supports diagnostic consideration in patients with exercise-induced pruritic wheals and provides material for education on recognition, documentation, and management planning. Relevance spans dermatology, allergology, pediatrics, and sports medicine; can guide antihistamine therapy, pre-exercise prophylaxis, and patient counseling on trigger avoidance and skin care during heat stress. Documentation of such patterns supports longitudinal monitoring and therapeutic response assessment.

Clinical photograph of a left forearm demonstrating dermatographism (skin writing), a form of physical urticaria. The image shows three distinct, raised, linear wheals (urticarial lesions) running longitudinally along the forearm. These markings are characteristically pale or erythematous with well-defined borders against the surrounding skin. The appearance is a classic representation of the triple response of Lewis, specifically the localized edema (wheal) that occurs in response to firm stroking or mechanical pressure on the skin. This finding is often associated with mast cell degranulation and histamine release in sensitive individuals. The photograph serves as an educational example for diagnosing physical urticarias and understanding the cutaneous manifestations of hyperreactivity in the dermatology and allergy/immunology domains.

Clinical photograph of a left forearm demonstrating dermatographism (skin writing), a form of physical urticaria. The image shows three distinct, raised, linear wheals (urticarial lesions) running longitudinally along the forearm. These markings are characteristically pale or erythematous with well-defined borders against the surrounding skin. The appearance is a classic representation of the triple response of Lewis, specifically the localized edema (wheal) that occurs in response to firm stroking or mechanical pressure on the skin. This finding is often associated with mast cell degranulation and histamine release in sensitive individuals. The photograph serves as an educational example for diagnosing physical urticarias and understanding the cutaneous manifestations of hyperreactivity in the dermatology and allergy/immunology domains.

Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Loading Image
Loading Image

Detailed Notes on Types of Urticaria


Master Classification Framework

Urticaria is classified by two axes: duration and trigger.
URTICARIA
├── SPONTANEOUS
│   ├── Acute Spontaneous (<6 weeks)
│   └── Chronic Spontaneous (≥6 weeks)
│       ├── Autoimmune
│       └── Idiopathic
└── INDUCIBLE (Physical)
    ├── Symptomatic Dermographism
    ├── Cholinergic Urticaria
    ├── Cold Urticaria
    ├── Heat Urticaria
    ├── Delayed Pressure Urticaria
    ├── Solar Urticaria
    ├── Aquagenic Urticaria
    ├── Vibratory Angioedema
    ├── Contact Urticaria
    └── Adrenergic Urticaria

SPECIAL ENTITIES
    ├── Urticarial Vasculitis
    ├── Angioedema (including HAE)
    └── Papular Urticaria
Physical/inducible urticarias account for up to 35% of all urticarias, occurring most commonly in persons aged 17-40.
  • Andrews' Diseases of the Skin, p. 176
  • Fitzpatrick's Dermatology, Vol. 1-2

PART 1: SPONTANEOUS URTICARIA

1A. Acute Spontaneous Urticaria

FeatureDetails
Duration< 6 weeks
PrevalenceMost new-onset urticaria (>2/3 of cases)
Common inChildren and young adults
Main causesViral URIs (most common in children), drugs (NSAIDs, antibiotics), foods, insect stings
Workup neededUsually none; history + exam sufficient
PrognosisSelf-limited; resolves once trigger removed
Key triggers:
  • Infections: rhinovirus, rotavirus, EBV (mononucleosis), hepatitis B/C, Coxsackievirus, psittacosis
  • Drugs: penicillin, NSAIDs, opioids, radiocontrast dye, vancomycin
  • Foods: shellfish, peanuts, tree nuts, eggs, milk, strawberries, lobster, chocolate, tomatoes, spices
  • Food additives: azo dyes, benzoic acid, sulfites, tartrazine
  • Inhalants: grass pollen, house dust mites, animal dander, molds, formaldehyde
  • Andrews' Diseases of the Skin, p. 175

1B. Chronic Spontaneous Urticaria (CSU)

FeatureDetails
Duration≥ 6 weeks, occurring almost daily
Prevalence~0.5-1% of population; 66-93% of chronic urticaria cases
DemographicsWomen > men (2:1); peak age 20-40 years
Cause identified< 20% of cases; majority remain idiopathic
Duration of disease50% have symptoms ≥ 5 years
Associated features:
  • Wheals + angioedema: 33-67% of CSU patients
  • Wheals only: 29-65%
  • Angioedema only: 1-13%
  • Flower-like or annular-shaped wheals are characteristic
  • Stress and fatigue are common aggravating factors; depression/anxiety are comorbidities
Investigations for CSU:
  • Routine: CBC with differential, ESR or CRP
  • Extended (based on history): H. pylori testing, thyroid antibodies (anti-TPO, anti-Tg), autologous serum skin test (ASST), tryptase (rule out mastocytosis), allergy skin tests, skin biopsy
  • Fitzpatrick's Dermatology, p. 717-723
  • Harrison's 22E, p. 2852

1C. Autoimmune Urticaria (subset of CSU)

FeatureDetails
PrevalenceUp to 45% of chronic urticaria patients
MechanismIgG autoantibodies against IgE or against the alpha chain of the high-affinity IgE receptor (FcεRI)
DetectionAutologous serum skin test (ASST): inject patient's own serum intradermally → positive wheal-and-flare
Basophil testingAutoantibodies induce CD63 or CD203c expression on basophils (activation markers)
Associated conditionsHashimoto's thyroiditis (euthyroid or clinical), SLE
Response to RxOften requires omalizumab or cyclosporine; antihistamines alone frequently insufficient
  • Harrison's Principles of Internal Medicine 22E, p. 2851

PART 2: INDUCIBLE (PHYSICAL) URTICARIAS


2A. Symptomatic Dermographism (Urticaria Factitia)

Dermatographism: linear wheals from skin stroking
FeatureDetails
DefinitionLinear wheal + erythema at site of a brisk stroke with a firm object
Prevalence2-5% of population; most common inducible urticaria
DemographicsPeak in 2nd-3rd decades; not influenced by atopy
MechanismMast cell degranulation (piecemeal/zonal pattern) with histamine release
Duration of diseaseGenerally < 5 years
Provocation testStroke skin firmly (e.g., tongue blade) - wheal appears within minutes
TreatmentH1 antihistamines (first-line); threshold testing to gauge response
Also called: "skin writing" - the word "urticaria" can be literally written on the skin.
  • Harrison's 22E, p. 2850; Andrews' Diseases of the Skin

2B. Cholinergic Urticaria

Cholinergic urticaria: tiny punctate wheals with large erythematous flare
FeatureDetails
TriggerRise in core body temperature (exercise, hot bath/shower, fever, emotional stress)
MorphologyMinute 1-3 mm wheals surrounded by large erythematous flare - very distinctive
LocationPrimarily trunk and face; spares palms and soles
DurationLesions persist 30-90 min; followed by refractory period up to 24 hours
MechanismAcetylcholine acts on mast cells; ~2/3 of patients have IgE antibodies to sweat antigens
ComplicationsBronchospasm may occur; familial cases reported
Provocation testExercise or warm bath raising core temperature by 0.7-1.0°C
Abort an attackRapid cooling (cold shower) may abort an attack
Treatment:
  • H1 antihistamines (first-line)
  • Add H2 antihistamine for additional benefit
  • Combine with montelukast and propranolol in refractory cases
  • Danazol (attenuated androgen) for refractory cases
  • Omalizumab for severe refractory cases
  • Andrews' Diseases of the Skin, p. 176; Harrison's 22E

2C. Cold Urticaria

FeatureDetails
TriggerExposure to cold air, cold water, cold objects
Key featureWheals develop on rewarming, NOT during cold exposure
LocationUsually localized to exposed areas (face, hands)
Life-threatening riskFatal anaphylaxis/shock from cold water immersion or cold shower - patients must carry epinephrine
Classification of Cold Urticaria:
TypeFeatures
Primary (Essential)No underlying disease or cold-reactive proteins; begins in adulthood; localized to cold-exposed areas
SecondaryAssociated with cryoglobulins, cold agglutinins (up to 5% of cases), infections (hepatitis, EBV), SLE
FamilialRare; autosomal dominant; mutations in NLRP3 (inflammasome) → familial cold autoinflammatory syndrome
Provocation test: Ice cube placement on volar forearm - wheal/angioedema within minutes
Mechanism: Ice cube provocation shows marked mast cell degranulation + elevated histamine levels in venous effluent; pattern resembles IgE-mediated response
Treatment: Antihistamines; avoid cold exposure; carry epinephrine auto-injector; cyproheptadine is classically used
  • Andrews' Diseases of the Skin; Harrison's 22E, p. 2851

2D. Delayed Pressure Urticaria

FeatureDetails
TriggerSustained pressure after a delay of 4-6 hours
ExamplesShoulder strap, belt, running (feet), manual labor (hands), sitting
MorphologyDeep, painful edematous swellings at pressure sites
AssociationFrequently accompanies chronic spontaneous urticaria
DelayCharacteristic 4-6 hour delay between pressure and wheal
TreatmentResponds poorly to antihistamines; NSAIDs, dapsone, or systemic steroids sometimes needed
Diagnostic test: Apply 15 lb weight over shoulder for 15 minutes; assess 4-6 hours later
  • Harrison's 22E; Andrews' Diseases of the Skin

2E. Solar Urticaria

FeatureDetails
TriggerUltraviolet (UV) or visible light exposure
OnsetMinutes after sun exposure
ResolutionWithin hours of removing light source
Classification6 subtypes based on wavelength of light causing reaction
ComplicationsSevere cases: systemic reaction with exposed large body surface area
TreatmentAntihistamines; photoprotection; phototherapy (hardening/tolerance induction); omalizumab
Diagnostic test: UV and visible light of different wavelengths with threshold testing (as per EAACI guidelines)
  • Fitzpatrick's Dermatology, Table 41-1; Harrison's 22E

2F. Heat Urticaria

FeatureDetails
TriggerLocal heat application to skin
DistinctionDifferent from cholinergic urticaria (which is triggered by rise in core temperature; heat urticaria is local)
Provocation testApply warm object to skin; measure threshold temperature
TreatmentAntihistamines

2G. Aquagenic Urticaria

FeatureDetails
TriggerContact with water at any temperature
Rare conditionVery uncommon
AssociationSometimes associated with polycythemia vera
DistinctionDifferent from cold urticaria (which is temperature-dependent)
TreatmentAntihistamines; barrier creams before water contact

2H. Vibratory Angioedema/Urticaria

FeatureDetails
TriggerVibration (using vibrating machinery, running, towel drying)
OnsetWithin minutes of vibration exposure
Hereditary formAutosomal dominant; mutation in ADGRE2 gene (mast cell mechanoreceptor) - identified recently
Acquired formAfter years of occupational exposure (e.g., jackhammer operators)
AssociationMay accompany cholinergic urticaria
Diagnostic testVortex mixer or vibration device applied to forearm
TreatmentAvoidance; antihistamines
  • Harrison's 22E, p. 2851; Fitzpatrick's Dermatology

2I. Contact Urticaria

FeatureDetails
TriggerDirect skin/mucosal contact with chemical or protein allergen
MechanismImmunologic (IgE-mediated) or non-immunologic
Common allergensLatex (with cross-reactivity to chestnuts, bananas, avocado, kiwi, passion fruit), foods, plants, medications, cosmetics
Latex cross-reactionImportant to recognize - latex allergy patients may react to these foods
TreatmentAvoidance; antihistamines

2J. Adrenergic Urticaria

FeatureDetails
TriggerEmotional upset, coffee, chocolate
MorphologySmall (1-5 mm) red macules/papules with pale halo (distinguishes from cholinergic)
OnsetWithin 10-15 minutes of trigger
MechanismMediated by norepinephrine (not acetylcholine) - serum catecholamines elevated during attacks
Key distinctionHistamine and serotonin levels are NORMAL (unlike cholinergic)
May coexistCan occur with cholinergic urticaria
Provocation testIntradermal injection of 3-10 ng of norepinephrine
TreatmentPropranolol 10 mg QID (effective); atenolol is ineffective; anxiolytic benzodiazepines for refractory cases
  • Andrews' Diseases of the Skin, p. 176

PART 3: SPECIAL ENTITIES

3A. Urticarial Vasculitis

FeatureDetails
Prevalence5-10% of patients with "fixed" urticarial lesions
Key distinguishing featuresSee table below
How to distinguish from ordinary urticaria:
FeatureTrue UrticariaUrticarial Vasculitis
SymptomPruriticBurning or painful (not pruritic)
Duration< 24 hours, transient> 24 hours, fixed
ResolutionCleanPostinflammatory purpura/hyperpigmentation
HistologyDermal edemaLeukocytoclastic vasculitis
Antihistamine responseGoodPoor
Two forms:
TypeFeatures
NormocomplementemicLimited to skin; idiopathic; self-resolving; subset of cutaneous small-vessel vasculitis
HypocomplementemicAlmost always in women; ↓C1q, C3, C4; anti-C1q antibodies; arthritis (50-82%), angioedema, eye symptoms (56%), asthma (20%), GI symptoms (20%), glomerulonephritis; >50% eventually meet SLE criteria
Associated diseases: SLE, Sjögren syndrome, gammopathy (IgG/IgM), serum sickness, hepatitis C
Drug causes: Penicillin, cimetidine, cocaine, NSAIDs, SSRIs, SSKI, TNF-inhibitors
Workup: CH50, C3, C4, anti-C1q antibodies, ANA, anti-dsDNA, skin biopsy (essential)
Treatment:
  • Antihistamines (often ineffective for hypocomplementemic type)
  • Indomethacin (particularly effective)
  • Dapsone, antimalarials (hydroxychloroquine), colchicine
  • Pentoxifylline as add-on
  • Severe cases: corticosteroids, immunosuppressives, omalizumab
  • Andrews' Diseases of the Skin, p. 4254-4282

3B. Angioedema

Definition: Urticaria that extends into the deep dermis and subcutaneous/submucosal tissues
Two subsets:
TypeFeatures
Histaminergic (deep urticaria)Solitary or multiple sites; associated with hives; pruritic; vasomotor lability; responds to antihistamines/epinephrine
Bradykinin-mediated (HAE/ACE-inhibitor)No hives, no pruritus; pain predominates; GI involvement; lasts >24h; does NOT respond to antihistamines/epinephrine
Hereditary Angioedema (HAE):
  • Also called Quincke edema; originally described by Osler (1888)
  • Autosomal dominant; SERPING1 gene mutation; 1 in 30,000-80,000 population
  • Onset before age 20; attacks every 2 weeks lasting 2-5 days
  • Asymmetric swelling; no urticaria, no pruritus
  • Life-threatening: laryngeal edema (fatal if untreated)
  • GI attacks mimic appendicitis (can lead to unnecessary surgery)
HAE TypeC1INH AntigenC1INH FunctionC4C1q
Type I (85%)LowLowLowNormal
Type IINormal/HighLowLowNormal
Type IIINormalNormalNormalNormal
Screening test of choice: C4 level (will be low in Types I and II even between attacks)
Treatment of HAE:
  • Acute attack: Plasma-derived or recombinant C1 inhibitor; ecallantide (kallikrein inhibitor); icatibant (bradykinin B2 receptor antagonist)
  • Short-term prophylaxis (pre-surgery/dental): C1 inhibitor replacement or danazol
  • Long-term prophylaxis: Attenuated androgens (danazol), antifibrinolytics (tranexamic acid), C1 inhibitor replacement, lanadelumab (anti-kallikrein monoclonal antibody)
  • Estrogens/OCPs precipitate attacks - avoid!
  • Antihistamines, epinephrine, corticosteroids have minimal/no effect on HAE
  • Andrews' Diseases of the Skin, p. 3300-3311; Harrison's 22E, p. 2852

3C. Papular Urticaria

FeatureDetails
CauseHypersensitivity reaction to insect bites (fleas, mosquitoes, bed bugs, mites)
Common inChildren
MorphologyPruritic papules/papulovesicles at bite sites; may be grouped
DistributionExposed areas (legs, arms)
TreatmentInsect avoidance, antihistamines, low-potency topical steroids

PART 4: DIAGNOSTIC TESTING SUMMARY (EAACI Guidelines)

Urticaria SubtypeRoutine TestExtended Test
Acute spontaneousNoneNone (unless allergy suspected)
CSUCBC, ESR/CRPH. pylori, thyroid antibodies, ASST, tryptase, biopsy
Cold urticariaCold provocation + threshold testDifferential CBC, ESR/CRP, rule out infections
Delayed pressurePressure test + thresholdNone
Heat urticariaHeat provocation + thresholdNone
Solar urticariaMulti-wavelength UV/visible light testingRule out other photodermatoses
DermographismDermographometer + thresholdCBC, ESR/CRP
CholinergicExercise/heat provocation + thresholdNone
VibratoryVortex or mixer vibration testNone
AquagenicWater provocationNone
Contact urticariaProvocation at contact siteNone
Source: Fitzpatrick's Dermatology (EAACI/GA2LEN/EDF/WAO 2018 Guideline), Table 41-1

PART 5: TREATMENT ALGORITHM (Step-Up Approach)

STEP 1 ─── Identify and remove trigger
            Non-sedating H1 antihistamine (cetirizine, loratadine, fexofenadine)
            [Standard dose]

STEP 2 ─── Increase H1 antihistamine up to 4x daily dosing
            Add H2 antihistamine (ranitidine/famotidine)
            Add leukotriene receptor antagonist (montelukast 10 mg/day)

STEP 3 ─── OMALIZUMAB (anti-IgE monoclonal antibody)
            [For CSU failing Steps 1-2]
            Evidence: very effective, including pediatric CSU

STEP 4 ─── CYCLOSPORINE (immunosuppressant)
            [For CSU with autoimmune component, omalizumab failure]
            Second-line immunosuppression

ADJUNCTS
  • Short course corticosteroids (prednisone 14-21 days with taper)
  • Not for chronic use
  • For HAE: C1 inhibitor / icatibant / ecallantide (NOT antihistamines)
  • For urticarial vasculitis: indomethacin, dapsone, antimalarials
Sources: Harrison's Principles of Internal Medicine 22E, p. 2852; Rosen's Emergency Medicine; Goldman-Cecil Medicine

QUICK COMPARISON TABLE: Key Inducible Urticarias

TypeTriggerWheal SizeKey FeatureTreatment
DermographismScratching/strokingLinear"Skin writing"; 2-5% prevalenceH1 antihistamines
CholinergicHeat, exercise, feverTiny 1-3 mm + large flareSpares palms/soles; refractory periodH1 ± H2, propranolol
AdrenergicStress, coffee, chocolateSmall 1-5 mm, pale haloNormal histamine; high catecholaminesPropranolol
ColdCold exposureVariesWheals on rewarming; anaphylaxis riskAntihistamines; epinephrine
Pressure (delayed)Sustained pressureDeep, painful4-6 hour delaySteroids; dapsone
SolarUV/visible lightVaries6 subtypes by wavelengthAntihistamines; photoprotection
AquagenicWater (any temp)Tiny punctateAssociated with polycythemia veraAntihistamines; barrier cream
VibratoryVibrationLocalizedADGRE2 mutation (hereditary form)Avoidance

Sources: Fitzpatrick's Dermatology Vol. 1-2 | Andrews' Diseases of the Skin, Clinical Dermatology | Harrison's Principles of Internal Medicine 22E | Goldman-Cecil Medicine | Rosen's Emergency Medicine

Pathology of urticaria

Finding Sources
Searching Images

urticaria histology mast cell degranulation dermal edema microscopy

Imaging modality: Light microscopy of a hematoxylin and eosin stained skin biopsy (dermis). The section demonstrates a sparse dermal infiltrate of mast cells in a perivascular distribution within the superficial to mid dermis, adjacent to collagen and small vessels. Mast cells appear as round to oval basophilic nuclei with granulated cytoplasm; the background stroma shows mild edema and mild perivascular lymphocytic inflammation. The infiltrate is not dense, supporting a clinical diagnosis of urticaria pigmentosa (cutaneous mastocytosis) rather than a mast cell proliferation with extensive infiltration. The epidermis is relatively preserved; no pseudoepitheliomatous hyperplasia; no significant fibrosis. Special stains or immunohistochemistry with CD117 (c-kit) or tryptase would enhance confirmation, as normal skin contains few dermal mast cells. Clinically, this histology correlates with pruritus, flush, Darier sign, and pigmentary changes. Diagnostic significance: Supports cutaneous mastocytosis; helps differentiate from pigmented nevi or dermatitis without mast cell infiltration. Differential considerations include other forms of cutaneous mastocytosis, pigmented lesions, and inflammatory dermatoses with inflammatory infiltrates. This image is educational for dermatopathology and histology of urticaria pigmentosa, and can guide workup for systemic involvement if clinically indicated. Terminology: cutaneous mastocytosis; mast cell tryptase testing; KIT mutation assessment may follow.

Imaging modality: Light microscopy of a hematoxylin and eosin stained skin biopsy (dermis). The section demonstrates a sparse dermal infiltrate of mast cells in a perivascular distribution within the superficial to mid dermis, adjacent to collagen and small vessels. Mast cells appear as round to oval basophilic nuclei with granulated cytoplasm; the background stroma shows mild edema and mild perivascular lymphocytic inflammation. The infiltrate is not dense, supporting a clinical diagnosis of urticaria pigmentosa (cutaneous mastocytosis) rather than a mast cell proliferation with extensive infiltration. The epidermis is relatively preserved; no pseudoepitheliomatous hyperplasia; no significant fibrosis. Special stains or immunohistochemistry with CD117 (c-kit) or tryptase would enhance confirmation, as normal skin contains few dermal mast cells. Clinically, this histology correlates with pruritus, flush, Darier sign, and pigmentary changes. Diagnostic significance: Supports cutaneous mastocytosis; helps differentiate from pigmented nevi or dermatitis without mast cell infiltration. Differential considerations include other forms of cutaneous mastocytosis, pigmented lesions, and inflammatory dermatoses with inflammatory infiltrates. This image is educational for dermatopathology and histology of urticaria pigmentosa, and can guide workup for systemic involvement if clinically indicated. Terminology: cutaneous mastocytosis; mast cell tryptase testing; KIT mutation assessment may follow.

This histopathology image demonstrates a dermatologic mast cell infiltrate associated with urticaria pigmentosa (cutaneous mastocytosis). Acquired lesion is evaluated on a formalin-fixed skin biopsy processed for light microscopy. The section shows dense sheets of round to oval, sometimes spindle-shaped mast cells occupying the superficial to mid-dermis. Individual cells exhibit uniform nuclei with clumped chromatin and moderate eosinophilic to amphophilic cytoplasm; cytoplasmic granules are faintly visible. The overall pattern lacks conspicuous epithelial involvement and displays a perivascular, often diffuse dermal distribution rather than compact clusters. Immunophenotypic context typically includes CD117 (c-KIT) positivity of neoplastic mast cells; aberrant CD25/CD2 expression may be present in some cases of systemic mastocytosis but is not consistently seen in reactive mast cell hyperplasia. In reactive conditions, mast cells are more loosely scattered with a perivascular tendency and are usually CD25/CD2 negative. Clinically, this histology supports a diagnosis of cutaneous mastocytosis when correlated with clinical findings such as pruritus, Darier sign, or urticarial plaques. The image is educational for dermatopathology, pathology residents, and clinicians, illustrating differential considerations with reactive mast cell hyperplasia and mastocytosis. It may guide immunohistochemical workup and subsequent systemic evaluation if warranted. for education.

This histopathology image demonstrates a dermatologic mast cell infiltrate associated with urticaria pigmentosa (cutaneous mastocytosis). Acquired lesion is evaluated on a formalin-fixed skin biopsy processed for light microscopy. The section shows dense sheets of round to oval, sometimes spindle-shaped mast cells occupying the superficial to mid-dermis. Individual cells exhibit uniform nuclei with clumped chromatin and moderate eosinophilic to amphophilic cytoplasm; cytoplasmic granules are faintly visible. The overall pattern lacks conspicuous epithelial involvement and displays a perivascular, often diffuse dermal distribution rather than compact clusters. Immunophenotypic context typically includes CD117 (c-KIT) positivity of neoplastic mast cells; aberrant CD25/CD2 expression may be present in some cases of systemic mastocytosis but is not consistently seen in reactive mast cell hyperplasia. In reactive conditions, mast cells are more loosely scattered with a perivascular tendency and are usually CD25/CD2 negative. Clinically, this histology supports a diagnosis of cutaneous mastocytosis when correlated with clinical findings such as pruritus, Darier sign, or urticarial plaques. The image is educational for dermatopathology, pathology residents, and clinicians, illustrating differential considerations with reactive mast cell hyperplasia and mastocytosis. It may guide immunohistochemical workup and subsequent systemic evaluation if warranted. for education.

This is a histopathology image of a skin biopsy stained with hematoxylin and eosin, showing a dense dermal mast cell infiltrate consistent with urticaria pigmentosa (cutaneous mastocytosis). The neoplastic mast cells are uniform, arranged in sheets within the reticular dermis, with oval to spindle-shaped morphology and ample eosinophilic or amphophilic cytoplasm containing visible granules. Nuclei are round to oval with clumped chromatin and inconspicuous nucleoli; binucleated cells may be present. Cytologic atypia is not a prominent feature, supporting a benign or indolent mast cell proliferation rather than high-grade disease. The surrounding stroma shows mild edema and occasional inflammatory cells; blood vessels are unaffected. Immunohistochemistry for CD117 (c-KIT) would typically be positive, and toluidine blue or other mast cell stains would highlight granules, confirming mast cell lineage. Clinically, this histology correlates with pigmented, pruritic lesions that characteristically degranulate on mechanical stimulation (Darier's sign). The image captures the key diagnostic features: sheets of uniform mast cells in the dermis, minimal pleomorphism, and absence of marked mitotic activity. This pattern helps distinguish cutaneous mastocytosis from reactive mast cell hyperplasia; however, assessment for systemic involvement (serum tryptase, KIT mutational status, organomegaly) may be warranted in broader clinical contexts.

This is a histopathology image of a skin biopsy stained with hematoxylin and eosin, showing a dense dermal mast cell infiltrate consistent with urticaria pigmentosa (cutaneous mastocytosis). The neoplastic mast cells are uniform, arranged in sheets within the reticular dermis, with oval to spindle-shaped morphology and ample eosinophilic or amphophilic cytoplasm containing visible granules. Nuclei are round to oval with clumped chromatin and inconspicuous nucleoli; binucleated cells may be present. Cytologic atypia is not a prominent feature, supporting a benign or indolent mast cell proliferation rather than high-grade disease. The surrounding stroma shows mild edema and occasional inflammatory cells; blood vessels are unaffected. Immunohistochemistry for CD117 (c-KIT) would typically be positive, and toluidine blue or other mast cell stains would highlight granules, confirming mast cell lineage. Clinically, this histology correlates with pigmented, pruritic lesions that characteristically degranulate on mechanical stimulation (Darier's sign). The image captures the key diagnostic features: sheets of uniform mast cells in the dermis, minimal pleomorphism, and absence of marked mitotic activity. This pattern helps distinguish cutaneous mastocytosis from reactive mast cell hyperplasia; however, assessment for systemic involvement (serum tryptase, KIT mutational status, organomegaly) may be warranted in broader clinical contexts.

Clinical photograph documenting pressure urticaria on the forearms. This in vivo, noninvasive Digital photography captures bilateral erythematous plaques and diffuse surface redness following sustained mechanical pressure. The forearms (bilateral) show symmetric involvement of the ventral/volar aspects near the antecubital region with a uniform, diffuse erythema and subtle edema without purpura or necrosis. The appearance is consistent with urticarial wheals produced by mast cell degranulation and superficial dermal edema in response to physical stimulation. The photo exemplifies a transient, pressure-induced skin reaction that typically waxes and wanes with time and relief of pressure. The imaging modality is clinical photography using a standard digital camera under ambient lighting, not contrast-enhanced, not magnified. Staining or histology are Not applicable. This image is valuable for clinical documentation, patient education, and research on physical urticarias, including pressure urticaria and dermographism. Differential considerations include allergic contact dermatitis, erythema multiforme, cellulitis, and vasculitic eruptions, all of which can mimic redness but differ in onset, warmth, and distribution. Clinical correlation with history of pressure exposure, timing, pruritus, and response to antihistamines is essential for accurate diagnosis and management planning. Images of such reactions support education, triage, and monitoring treatment outcomes in dermatology and allergy clinics for broader research.

Clinical photograph documenting pressure urticaria on the forearms. This in vivo, noninvasive Digital photography captures bilateral erythematous plaques and diffuse surface redness following sustained mechanical pressure. The forearms (bilateral) show symmetric involvement of the ventral/volar aspects near the antecubital region with a uniform, diffuse erythema and subtle edema without purpura or necrosis. The appearance is consistent with urticarial wheals produced by mast cell degranulation and superficial dermal edema in response to physical stimulation. The photo exemplifies a transient, pressure-induced skin reaction that typically waxes and wanes with time and relief of pressure. The imaging modality is clinical photography using a standard digital camera under ambient lighting, not contrast-enhanced, not magnified. Staining or histology are Not applicable. This image is valuable for clinical documentation, patient education, and research on physical urticarias, including pressure urticaria and dermographism. Differential considerations include allergic contact dermatitis, erythema multiforme, cellulitis, and vasculitic eruptions, all of which can mimic redness but differ in onset, warmth, and distribution. Clinical correlation with history of pressure exposure, timing, pruritus, and response to antihistamines is essential for accurate diagnosis and management planning. Images of such reactions support education, triage, and monitoring treatment outcomes in dermatology and allergy clinics for broader research.

Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Reading File
Reading File
Loading Image
Reading File
Reading File
Loading Image
Loading Image
Reading File
Reading File
Reading File
Loading Image
Reading File
Excellent - I now have comprehensive pathology content with diagrams. Compiling the full detailed notes now.

Pathology of Urticaria - Detailed Notes


1. GROSS / MACROSCOPIC PATHOLOGY

The fundamental lesion of urticaria is the wheal - a result of localized dermal microvascular hyperpermeability.
FeatureDescription
MorphologyRaised, edematous plaques with central pallor (pale/white center) and peripheral erythematous flare
SizeA few mm to as large as a hand; may coalesce into larger plaques
ColorPink to pale (whiter when edema is more prominent)
SurfaceSmooth; no scaling, no vesicles, no necrosis
HallmarkEach individual lesion comes and goes within < 24 hours
PruritusHallmark symptom
AngioedemaWhen edema extends into deep dermis/subcutaneous tissue: faint pink, painful, less defined, lasts 2-3 days
  • Dermatology 5e (Grattan, Kocatürk, Saini), p. 372
  • Robbins & Kumar Basic Pathology, p. 879

2. HISTOPATHOLOGY (Microscopic Pathology)

Classic Histologic Findings

The histologic features of urticaria are characteristically subtle - in stark contrast to the dramatic clinical appearance.
LayerFindings
EpidermisNormal; no spongiosis, no acanthosis
Superficial dermisEdema - collagen bundles are widely spaced ("splaying") due to accumulated fluid
Blood vesselsDilated postcapillary venules; endothelium normal (in ordinary urticaria)
Inflammatory infiltrateSparse mixed perivascular infiltrate around superficial and mid-dermal venules
Cell typesLymphocytes (predominant), eosinophils, basophils, some neutrophils
Mast cellsDegranulated mast cells around superficial dermal venules; appear pale/empty
Key microscopic point: In routine H&E stain, mast cells are difficult to see. They are better visualized with Giemsa stain or toluidine blue (both highlight the metachromatic granules).
  • Robbins & Kumar Basic Pathology, p. 879
  • Dermatology 5e, p. 382

Histologic Variants

VariantMicroscopic PatternClinical Significance
Classic/Lymphocytic urticariaSparse perivascular lymphocytes + mild edemaMost common; typical CSU
Neutrophilic urticariaPredominantly neutrophilic dermal infiltrate (no vasculitis features)May indicate autoinflammatory syndrome (CAPS, Schnitzler, Still disease, SLE)
Urticarial vasculitisLeukocytoclastic vasculitis: endothelial damage, perivenular neutrophil-rich infiltrate, karyorrhexis (nuclear dust), fibrinoid deposits in vessel walls, erythrocyte extravasationHypocomplementemic form = systemic disease (SLE overlap)
Urticarial bullous pemphigoidEosinophil-rich infiltrate; subepidermal blisterPre-bullous pemphigoid; lesions last >24h
Rule: If urticarial lesions consistently persist >24-36 hours, are painful rather than pruritic, and leave bruising/pigmentation on resolution → biopsy is mandatory to rule out urticarial vasculitis.
  • Dermatology 5e, p. 382

3. PATHOGENESIS - CELLULAR AND MOLECULAR

The Central Event: Mast Cell Degranulation

The mast cell is the primary effector cell of urticaria.
Two mast cell phenotypes in skin:
TypeLocationContentsIgE receptor
MCTC (tryptase + chymase)Skin, intestinal submucosaTryptase + chymaseYes (FcεRI)
MCT (tryptase only)Bowel mucosa, alveolar wall, nasal mucosaTryptase onlyYes (FcεRI)
Both types express FcεRI and can participate in IgE-dependent reactions. Cutaneous mast cells in urticaria are more "releasable" - they degranulate more readily in response to stimuli (e.g., intradermal codeine injection).

Step-by-Step Degranulation Mechanism

Trigger (antigen/autoantibody/physical stimulus)Cross-linking of 2+ adjacent FcεRI receptors on mast cell membraneCalcium- and energy-dependent signaling cascade (SYK → LAT → PLCγ → PKC) ↓ Fusion of storage granules with cell membraneExternalization of granule contents (degranulation)Mediator release → vasodilation + vascular permeability → edema + pruritus

Mast Cell Degranulating Stimuli

Mast cell degranulating stimuli diagram showing FcεRI cross-linking by allergen/anti-FcεRI/anti-IgE, plus non-immunologic pathways via MRGPRX2 (substance P, opioids), stem cell factor (KIT receptor), and C5a
Fig. Mast cell degranulating stimuli - Dermatology 5e
PathwayStimulusReceptor
Immunologic (IgE-dependent)Allergen cross-links IgE-bound FcεRIFcεRI
Immunologic (autoantibody)Anti-IgE IgG, anti-FcεRI IgGFcεRI
Complement-mediatedC5a anaphylatoxinC5a receptor
Non-immunologicOpioids, codeine, substance P, polymyxin BMRGPRX2 receptor
Growth factorStem cell factorKIT receptor
Physical stimuliCold, pressure, vibration, UV, heatVarious / indirect

4. INFLAMMATORY MEDIATORS RELEASED

Mast cell mediators diagram: preformed (histamine, heparin, tryptase/proteases) and newly synthesized (PGD2, LTC4, LTD4, LTE4, PAF, cytokines IL-3/-4/-5/-6/-8/-13, GM-CSF, TNF)
Fig. Mediators released by human dermal mast cell degranulation - Dermatology 5e

Preformed Mediators (stored in granules, released immediately)

MediatorRole in Urticaria
HistaminePrimary mediator; binds H1 receptors on postcapillary venules → vasodilation + increased permeability; acts on sensory nerves → itch
TryptaseSerine protease; activates bradykinin; used as marker of mast cell activation (serum tryptase)
ChymaseSerine protease; cleaves angiotensin I → angiotensin II; modulates matrix
HeparinAnticoagulant; binds growth factors; contributes to wheal formation
Chondroitin sulfateStructural proteoglycan component of granules

Newly Synthesized Mediators (formed after activation from membrane phospholipids)

MediatorRole
Prostaglandin D2 (PGD2)Most important eicosanoid; vasodilation + bronchoconstriction
PGE2Inhibitory - has protective role by inhibiting immunologic mast cell degranulation
Leukotriene C4, D4, E4= "Slow-reacting substance of anaphylaxis (SRS-A)"; prolonged vasodilation + wheal formation
Platelet-activating factor (PAF)Platelet aggregation; amplifies wheal formation; especially in cold urticaria
Cytokines: TNF, IL-1β, IL-3, IL-5, IL-6, IL-8, IL-10, IL-12p70, IL-13Upregulate endothelial adhesion molecules (ICAM-1, E-selectin); recruit eosinophils, basophils, neutrophils, Th0 cells into lesion
GM-CSFPromotes eosinophil/basophil survival
BAFF (B-cell activating factor)Elevated in CSU sera; may sustain autoantibody production
Key downstream effect on vessels: Histamine, TNF, and IL-8 upregulate adhesion molecule expression on endothelial cells → promote migration of circulating inflammatory cells into urticarial lesions.
  • Dermatology 5e, p. 374
  • Fitzpatrick's Dermatology, p. 720-721

5. IMMUNOLOGIC MECHANISMS (DETAILED)

5A. Type I Hypersensitivity (IgE-Mediated)

IgE binding to FcεRI diagram showing α1 and α2 subunits of the extracellular domain with IgE, β and γγ transmembrane/cytoplasmic chains
Fig. IgE antibody binding to the high-affinity IgE receptor (FcεRI) - Dermatology 5e
  • Antigen-specific IgE coats mast cells via FcεRI
  • Re-exposure to antigen cross-links adjacent FcεRI → degranulation
  • Symptoms begin 15 min to 1 hour after allergen exposure
  • Probably accounts for < 10% of all urticaria (mainly acute/episodic forms)
  • Classic examples: latex contact urticaria, food allergy urticaria (nuts, fish, fruit)

5B. Autoimmune Mechanism (IgG Autoantibodies)

Autoantibody mechanism: IgG anti-FcεRI and anti-IgE autoantibodies activate mast cells/basophils → degranulation → histamine; C5a augments the process; omalizumab blocks free IgE → downregulates FcεRI expression
Fig. Mechanism of mast cell/basophil activation by autoantibodies and omalizumab's mechanism of action - Fitzpatrick's Dermatology
  • Affects 30-50% of CSU patients (up to 45% by some estimates)
  • Two types of pathogenic autoantibodies:
AutoantibodyTargetMechanism
IgG anti-FcεRI (majority)α subunit of high-affinity IgE receptorCross-links FcεRI → mast cell/basophil degranulation
IgG anti-IgE (~10%)Fc portion of IgE itselfCross-links IgE bound to FcεRI → degranulation
  • Anti-FcεRI subtypes:
    • Anti-α2 domain: competitive with IgE (blocks binding)
    • Anti-α1 domain: non-competitive (binds even in presence of IgE)
  • Complement amplification: Autoantibody binding → complement activation → C5a anaphylatoxin generated → further augments mast cell degranulation
  • Detection methods: Autologous serum skin test (ASST), basophil CD63/CD203c activation test, in vitro histamine release assay
  • IgE autoantibodies also found in CSU against: thyroid peroxidase (TPO), thyroglobulin, tissue factor, IL-24 → these IgE anti-TPO antibodies can produce a local wheal-and-flare, explaining the thyroid disease-urticaria association
  • Basophils in CSU: Blood basophils are reduced in number and less responsive to anti-IgE stimulus in active disease; responsiveness returns during remission
  • Omalizumab mechanism: Binds free IgE at its Cε3 domain (receptor binding site) → prevents IgE binding to FcεRI → gradual downregulation of FcεRI expression on mast cells → reduced mast cell "readiness" to degranulate
  • Dermatology 5e, p. 373-374; Fitzpatrick's Dermatology, p. 720-721; Harrison's 22E

5C. Immune Complex / Complement-Mediated

  • Urticarial vasculitis and serum-sickness type urticaria
  • Antigen-antibody complexes deposit in vessel walls → activate complement → C3a + C5a anaphylatoxins → mast cell degranulation AND direct vascular damage
  • Leads to leukocytoclastic vasculitis histologically

5D. Non-Immunologic (Direct Mast Cell Activation)

AgentReceptor/Mechanism
Opioids (morphine, codeine)MRGPRX2 receptor
Substance PMRGPRX2 receptor
Vancomycin ("red man syndrome")Direct MRGPRX2
Radiocontrast mediaDirect mast cell degranulation
Aspirin / NSAIDsShift arachidonic acid to leukotriene pathway (LOX > COX); non-immunologic
Strawberries, lobsterDirectly release histamine from mast cells

6. PATHOGENESIS OF SPECIFIC URTICARIA TYPES

TypeSpecific Pathological Mechanism
Cholinergic urticariaAcetylcholine released from cholinergic sympathetic nerves → mast cell activation; ~2/3 have IgE antibodies to MGL_1304 (protein from Malassezia globosa in sweat)
Cold urticariaProposed IgE-mediated neoantigen (cold-induced); cryoglobulins (5%); platelet clumping → PAF/platelet factor 4 release; familial form: F12 mutation → bradykinin pathway; FCAS: NLRP3 mutation → IL-1β
DermatographismZonal (piecemeal) mast cell degranulation pattern on electron microscopy; elevated histamine in suction blisters at dermographic sites
Pressure urticariaPossibly late-phase IgE reaction; no antigen identified
Vibratory urticaria (hereditary)ADGRE2 missense mutation → destabilizes inhibitory α/β subunit interaction → sensitizes mast cells to vibration-induced degranulation (IgE-independent)
Solar urticariaPhysical stimulus creates neoantigen → reacts with IgE on mast cells; 6 subtypes by action spectrum
Aquagenic urticariaWater dilutes inhibitory substance in skin → IgE mechanism? Pathomechanism unclear
HAE (not true urticaria)C1INH deficiency → failure to inhibit factor XII (Hageman factor) and kallikrein → bradykinin excess → vascular permeability (NOT histamine-dependent)

7. VASCULAR PATHOLOGY: HOW THE WHEAL FORMS

Mast cell degranulation
         ↓
Histamine released → binds H1 receptors on postcapillary venules
         ↓
┌─────────────────────────────────────┐
│ Vasodilation of arterioles          │  → ERYTHEMA (red flare)
│ Increased permeability of venules   │  → PLASMA EXTRAVASATION → EDEMA (wheal center pale)
│ Sensory nerve activation (itch)     │  → PRURITUS
└─────────────────────────────────────┘
         ↓
TNF + IL-8 upregulate endothelial adhesion molecules
(ICAM-1, E-selectin, VCAM-1)
         ↓
Eosinophils, basophils, neutrophils, Th0 cells migrate into dermis
         ↓
Late-phase reaction: secondary cytokine release → prolongs/amplifies inflammation
The triple response of Lewis in dermographism demonstrates this perfectly:
  1. Local red reaction (direct vasodilation)
  2. Surrounding flare (axon reflex via sensory nerves)
  3. Wheal (local edema from vascular leakage)

8. ROLE OF COAGULATION IN URTICARIA

A recently recognized pathomechanism in CSU:
  • Tissue factor is upregulated on eosinophils and monocytes in CSU
  • Leads to activation of the extrinsic coagulation cascade
  • Generates thrombin, which can directly activate PAR-1 receptors on mast cells → degranulation
  • D-dimer levels are elevated in active CSU and correlate with disease severity
  • This explains why anticoagulants (heparin) may reduce urticaria symptoms

9. SUMMARY TABLE: PATHOLOGY AT A GLANCE

LevelFinding
GrossEdematous wheal; pale center + red flare; transient (<24h); no scaling
HistologySuperficial dermal edema; splayed collagen bundles; sparse perivascular mixed infiltrate (lymphocytes, eos, basophils, neutrophils); degranulated mast cells
Special stainsMast cells: Giemsa/toluidine blue (metachromatic granules); tryptase immunostain
Key effector cellMast cell (cutaneous MCTC phenotype)
Primary mediatorHistamine (preformed, immediate)
Newly synthesizedPGD2, LTC4/D4/E4, PAF, cytokines (TNF, IL-6, IL-8)
Main receptorFcεRI (high-affinity IgE receptor) - α1β(γγ) subunit structure
Immunologic triggerIgE cross-linking (type I HSR) or IgG autoantibodies (anti-FcεRI / anti-IgE)
Non-immunologic triggerMRGPRX2 agonists (opioids, substance P, codeine)
Autoimmune mechanismIgG anti-FcεRI or anti-IgE in ~30-50% of CSU; C5a amplifies
Vasculitis variantLeukocytoclastic vasculitis; fibrinoid necrosis; erythrocyte extravasation

Sources: Dermatology 5e (Grattan, Kocatürk, Saini) | Fitzpatrick's Dermatology Vol. 1-2 | Robbins & Kumar Basic Pathology | Harrison's Principles of Internal Medicine 22E | Andrews' Diseases of the Skin
This is a shared conversation. Sign in to Orris to start your own chat.